These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

857 related items for PubMed ID: 12180000

  • 1. [Frequency of hyperhomocysteinemia in hemodialysis patients with folic acid supplementation].
    Kárpáti I, Balla J, Szóke G, Bereczky Z, Páll D, Ben T, Toma K, Katona E, Mohácsi A, Paragh G, Varga Z, Kakuk G, Muszbek L.
    Orv Hetil; 2002 Jul 07; 143(27):1635-40. PubMed ID: 12180000
    [Abstract] [Full Text] [Related]

  • 2. Methylenetetrahydrofolate reductase genotype, vitamin B12, and folate influence plasma homocysteine in hemodialysis patients.
    Nakamura T, Saionji K, Hiejima Y, Hirayama H, Tago K, Takano H, Tajiri M, Hayashi K, Kawabata M, Funamizu M, Makita Y, Hata A.
    Am J Kidney Dis; 2002 May 07; 39(5):1032-9. PubMed ID: 11979347
    [Abstract] [Full Text] [Related]

  • 3. The C677T thermolabile variant of methylene tetrahydrofolate reductase on homocysteine, folate and vitamin B12 in a hemodialysis center.
    Trimarchi H, Genoud V, Schiel A, Castañon M, Freixas E, Diaz ML, Schropp J, Martino D, Pereyra H, Kordich L.
    Medicina (B Aires); 2002 May 07; 62(2):149-53. PubMed ID: 12038037
    [Abstract] [Full Text] [Related]

  • 4. [Plasma homocysteine levels in patients with ischemic heart disease].
    Márk L, Erdei F, Márki-Zay J, Nagy E, Kondacs A, Katona A.
    Orv Hetil; 2001 Jul 29; 142(30):1611-5. PubMed ID: 11519232
    [Abstract] [Full Text] [Related]

  • 5. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients.
    Nakhoul F, Abassi Z, Plawner M, Khankin E, Ramadan R, Lanir N, Brenner B, Green J.
    Isr Med Assoc J; 2004 Apr 29; 6(4):213-7. PubMed ID: 15115259
    [Abstract] [Full Text] [Related]

  • 6. Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease.
    Hyndman ME, Manns BJ, Snyder FF, Bridge PJ, Scott-Douglas NW, Fung E, Parsons HG.
    Metabolism; 2003 Feb 29; 52(2):168-72. PubMed ID: 12601627
    [Abstract] [Full Text] [Related]

  • 7. Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal disease.
    Dierkes J, Domröse U, Ambrosch A, Bosselmann HP, Neumann KH, Luley C.
    Clin Nephrol; 1999 Feb 29; 51(2):108-15. PubMed ID: 10069646
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. G1793A polymorphisms in the methylene-tetrahydrofolate gene: effect of folic acid on homocysteine levels.
    Melo SS, Persuhn DC, Meirelles MS, Jordao AA, Vannucchi H.
    Mol Nutr Food Res; 2006 Aug 29; 50(8):769-74. PubMed ID: 16865747
    [Abstract] [Full Text] [Related]

  • 10. [The plasma homocysteine, folic acid and vitamin B12 levels in young people with high risk for cardiovascular disease and its relation to metylentetrahydrofolate reductase (MTHFR) gene polymorphism].
    Klujber V, Lengyel B, Szabó T, Németh A, Dobó M.
    Orv Hetil; 2005 Apr 03; 146(14):649-51. PubMed ID: 15889539
    [Abstract] [Full Text] [Related]

  • 11. Relationships between homocysteine and related amino acids in chronic hemodialysis patients.
    McDonald SP, Whiting MJ, Tallis GA, Barbara JA.
    Clin Nephrol; 2001 Jun 03; 55(6):465-70. PubMed ID: 11434358
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Plasma homocysteine after insulin infusion in type II diabetic patients with and without methionine intolerance.
    Ventura P, Panini R, Emiliani S, Salvioli G.
    Exp Clin Endocrinol Diabetes; 2004 Jan 03; 112(1):44-51. PubMed ID: 14758571
    [Abstract] [Full Text] [Related]

  • 14. Reduction of plasma homocysteine by folic acid in children with chronic renal failure.
    Kang HG, Lee BS, Hahn H, Lee JH, Ha IS, Cheong HI, Choi Y.
    Pediatr Nephrol; 2002 Jul 03; 17(7):511-4. PubMed ID: 12172764
    [Abstract] [Full Text] [Related]

  • 15. Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease.
    Andreassi MG, Botto N, Cocci F, Battaglia D, Antonioli E, Masetti S, Manfredi S, Colombo MG, Biagini A, Clerico A.
    Hum Genet; 2003 Feb 03; 112(2):171-7. PubMed ID: 12522558
    [Abstract] [Full Text] [Related]

  • 16. Hyperhomocysteinemia and hyperlipidemia in coronary heart disease.
    Gao W, Jiang N, Meng Z, Tang J.
    Chin Med J (Engl); 1999 Jul 03; 112(7):586-9. PubMed ID: 11601248
    [Abstract] [Full Text] [Related]

  • 17. Homocysteine, vitamin B12, serum and erythrocyte folate in peritoneal dialysis patients.
    De Vecchi AF, Bamonti-Catena F, Finazzi S, Patrosso C, Taioli E, Novembrino C, Colucci P, Lando G, De Franceschi M, Marocchi A, Maiolo AT.
    Clin Nephrol; 2001 Apr 03; 55(4):313-7. PubMed ID: 11334318
    [Abstract] [Full Text] [Related]

  • 18. Association of MTHFR and RFC1 gene polymorphism with hyperhomocysteinemia and its modulation by vitamin B12 and folic acid in an Indian population.
    Sukla KK, Raman R.
    Eur J Clin Nutr; 2012 Jan 03; 66(1):111-8. PubMed ID: 21878957
    [Abstract] [Full Text] [Related]

  • 19. Homocysteine concentration in primary and systemic sclerosis associated Raynaud's phenomenon.
    Marasini B, Casari S, Bestetti A, Maioli C, Cugno M, Zeni S, Turri O, Guagnellini E, Biondi ML.
    J Rheumatol; 2000 Nov 03; 27(11):2621-3. PubMed ID: 11093443
    [Abstract] [Full Text] [Related]

  • 20. Mild hyperhomocysteinemia and low folate concentrations as risk factors for cervical arterial dissection.
    Arauz A, Hoyos L, Cantú C, Jara A, Martínez L, García I, Fernández Mde L, Alonso E.
    Cerebrovasc Dis; 2007 Nov 03; 24(2-3):210-4. PubMed ID: 17596690
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.